Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Study Underway for Toro Neurovascular's SuperBore Aspiration Catheter - Medical Product Outsourcing
OEM News

Study Underway for Toro Neurovascular’s SuperBore Aspiration Catheter

The Toro 88 catheter is engineered for enhanced control and navigation through tortuous, challenging conditions.

Toro Neurovascular has treated the first patient in a clincal study of its Toro 88 SuperBore Aspiration Catheter. The procedure was performed by neurosurgeon Nobuyuki Sakai, M.D., and his staff at Shimizu Hospital in Japan. 
 
“Toro 88’s performance was exceptional, particularly in accessing the intricate anatomy of the cerebral vasculature,” stated Dr. Sakai, Seijinkai Shimizu Hospital president. “Its ability to efficiently remove large clot burden and navigate challenging conditions is impressive. I am pleased to be part of this study, which has the potential to significantly enhance stroke treatment and improve patient outcomes.”
 
Toro’s catheter technology is poised to establish a new standard for navigating complex neurovascular anatomy, the company claims. Featuring MicroFlex Technology, a reinforced micro-wire design, the Toro 88 catheter was engineered for enhanced control and navigation through tortuous, challenging conditions. Its advanced support profile is designed to provide exceptional maneuverability, precision, and efficient access the M1 segment of the middle cerebral artery (MCA). With a vessel-matched 0.088-inch lumen, Toro 88 aims to enable complete clot ingestion, potentially transforming patient outcomes.
 
“Our goal is to improve patient outcomes through innovation, and we are excited to showcase how our technology may streamline clot access and removal,” Toro Neurovascular CEO Hyung Posalit said. “We are committed to developing high-performance devices that make a meaningful difference in stroke patient outcomes. This milestone is a testament to our ongoing efforts to create real-world benefits for patients.”
 
Toro is driven by the potential to make a profound impact on thrombectomy procedures. The company believes its devices offer physicians an improved first-line stroke treatment, possibly delivering faster and more effective results. Toro catheters could significantly elevate the standard of stroke care and expand access to stroke therapy in developing regions, subject to regulatory approvals, the company believes.
 
The Toro 88 SuperBore Aspiration Catheter is not commercially available for use.
 
Toro Neurovascular designs advanced medical devices that incorporate cutting-edge technology to improve stroke care.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters